Polyhedron Crystal Nanoparticles for Protein Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for stabilizing and preserving functional proteins on support surfaces for applications like protein chips and biosensors are inefficient, as they fail to maintain the native conformation and biological activity of proteins, and there is a need for improved pharmaceutical formulations and delivery devices for therapeutic agents.
Innovation Solution
The development of modified Bombyx mori cypovirus 1 polyhedra complexes that incorporate target molecules into the polyhedron crystal structure, utilizing specific regions of the polyhedrin protein to ensure stability and functionality, allowing for the creation of robust nanoparticles for biotechnological applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to immobilize proteins on support surfaces, then proteins can be attached to surfaces, but the proteins fail to retain their native conformation and biological activity
Solution Approach 1:
The patent uses polyhedrin protein as an intermediary carrier that forms a protective crystal lattice structure. Target proteins are fused with polyhedrin and embedded within the polyhedral crystal, which acts as a mediator between the protein and the external environment, preserving the protein's native conformation and biological activity while providing structural stability.
Solution Approach 2:
The patent embeds target proteins within the nested crystal lattice structure of polyhedra. The polyhedral crystal serves as a protective container that houses the target protein molecules, similar to nested dolls, where the inner structure (target protein) is protected by the outer crystalline matrix, maintaining both conformation and activity.
2Reliability
If proteins are immobilized on chip surfaces for protein chips and biosensors, then analytical tools can be created, but the functional molecules are not stably maintained
Solution Approach 1:
The patent creates a composite material system where target proteins are fused with polyhedrin protein to form recombinant polyhedrin. This composite structure combines the functional properties of the target protein with the exceptional stability and protective characteristics of the polyhedrin crystal lattice, resulting in a material that maintains functional stability over extended periods.
Solution Approach 2:
The polyhedrin crystal lattice provides beforehand cushioning and protection for the embedded target proteins. The crystalline structure acts as a pre-established protective environment that shields the proteins from denaturation, aggregation, and environmental damage before they are exposed to harsh conditions, thereby extending their functional maintenance time.
3Stability of the object's composition
If therapeutic agents are transported and stored under special conditions, then drug stability is protected, but transportation cost increases and availability is reduced
Solution Approach 1:
The polyhedrin crystal lattice provides self-service protection for the embedded therapeutic agents. The crystalline structure inherently maintains a stable microenvironment that protects the drug molecules from degradation without requiring external intervention such as temperature control or special packaging, enabling stable transportation and storage under ambient conditions.
4Quantity of substance
If target proteins are incorporated into polyhedra using VP3 fusion, then proteins can be embedded in polyhedron, but the process requires complex protein chemistry and multiple steps
Solution Approach 1:
The patent utilizes the polyhedrin protein as a universal carrier that can accommodate diverse target proteins through fusion. The polyhedrin crystal lattice serves multiple functions: it provides structural stability, protects embedded proteins, enables high-throughput production, and facilitates various applications including protein chips, biosensors, and drug delivery, reducing the need for application-specific optimization steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the stabilization and prolonged functionality of target molecules, enhancing their stability against environmental damage and maintaining biological activity, which is crucial for protein microarrays, biosensors, and bio-pesticides, and provides a versatile means for drug delivery and bioavailability.
Implementation Method 1
The virus particles are embedded in the polyhedron via the constituent CPV envelope protein, VP3, which binds to the polyhedrin protein, the major viral protein making up the polyhedron. Polyhedra exhibit remarkable stability and, as such, the embedded insect viruses can remain infectious for years in the environment.
Implementation Method 2
co-expressing target proteins fused to a portion of a virion structural capsid protein, VP3 during CPV infection. The results indicated that incorporation of these proteins into the polyhedron crystal was successful and that the proteins were protected from dehydration and stabilized against high temperatures without the loss of function.
Data Source
Figure 1a~1d
Figure 2a~2c
Figure 3a~3b
AI summary
Cypoviruses and baculoviruses are notoriously difficult to eradicate because the virusparticles are embedded in micron-sized protein crystals called polyhedra. The remarkable stability of polyhedra means that like bacterial spores these insect viruses remain infectious for years in soil. Although these unique in vivo protein crystals have been extensively characterized since the early 1900s, their atomic organization remains elusive. Here we describe the 2Åcrystal structure of both recombinant and infectious silkworm cypovirus polyhedra determined using 5-12 micron crystals purified from insect cells. These are the smallest crystals yet used for de novo X-ray protein structure determination. It was found that polyhedra are made of trimers of the viral polyhedrin protein and contain nucleotides. Although the shape of these building blocks is reminiscent of some capsid trimers, polyhedrin has a new fold and has evolved to assemble in vivo into 3-D cubic crystals rather than icosahedral shells. The polyhedrin trimers are extensively cross-linked in polyhedra by non-covalent interactions and pack with an exquisite molecular complementarity similar to that of antigen-antibody complexes. The resulting ultra-stable and sealed crystals shield the virus particles from environmental damage. The structure suggests that polyhedra can serve as the basis for the development of robust and versatile nanoparticles for biotechnological applications such as in cell culture systems, microarrays and biopesticides.